Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Microtubule-associated protein tau becomes abnormally hyperphosphorylated in Alzheimer's disease (AD) and accumulates as tangles of paired helical filaments in neurons undergoing degeneration. We now show that in solution normal tau associates with the AD hyperphosphorylated tau (AD P-tau) in a nonsaturable fashion, forming large tangles of filaments 3.3 +/- 0.7 nm in diameter. These tangles, which are not detected in identically treated normal tau or AD P-tau alone, are made up of filaments several microns in length and are labeled with tau antibodies. Dephosphorylation with alkaline phosphatase abolishes the ability of AD P-tau to aggregate with normal tau and prevents tangle formation. AD P-tau disassembles microtubules assembled from normal tau and tubulin. These data provide insight into how the hyperphosphorylation of tau might lead to the formation of the neurofibrillary tangles and the degeneration of the affected neurons in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In AD, tau becomes hyperphosphorylated, causing it to detach from microtubules and form neurofibrillary tangles with other tau molecules [73].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [73]
In the citing paper
“a cytosolic pool of hyperphosphorylated tau has been observed in AD brain to sequester normal tau and disrupt the microtubule network (20)”
From An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease (2013) · cites this paper as [20]
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Self-citationAssay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Microtubule Assembly in the Absence of Added Nucleotides
Shelanski, M. L., Gaskin, F., & Cantor, C. R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.765 · Cited by 2,053
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Self-citationBancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Self-citationKöpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citationRole of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Self-citationDEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE
Iqbal, K., Zaidi, T., Wen, G., Grundke-Iqbal, I., Merz, P., Shaikh, S., Wisniewski, H., Alafuzoff, I., & Winblad, B. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92134-3 · Cited by 725
Self-citationHydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
Greenberg, S. G., Davies, P., Schein, J. D., & Binder, L. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48531-6 · Cited by 543
Cited by
Items 101–116 of 116
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50
Saha, P., & Biswas, S. C. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.002 · Cited by 43
Further understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
“Moreover, hyperphosphorylated tau also has the capacity of sequestering normal tau molecules (and perhaps other MAPs) into the aggregates, which will also negatively impact on the normal MT function [35].”
BackgroundHyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy
Takashima, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14403 · Cited by 40
Beharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39
Self-citationBasurto-Islas, G., Gu, J.-H., Tung, Y. C., Liu, F., & Iqbal, K. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170715 · Cited by 39
Self-citationHannan, S. B., Dräger, N. M., Rasse, T. M., Voigt, A., & Jahn, T. R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13532 · Cited by 38
Tau and Alzheimer's disease: Past, present and future
Iqbal, K. (2024) · Cytoskeleton · doi:10.1002/cm.21822 · Cited by 35
Self-citationLevels of tau phosphorylation at different sites in Alzheimer disease brain
Ikura, Y., Kudo, T., Tanaka, T., Tanii, H., Grundke-Iqbal, I., Iqbal, K., & Takeda, M. (1998) · NeuroReport · doi:10.1097/00001756-199807130-00041 · Cited by 31
Self-citationZhang, L., Xie, J., Yang, J., & Cao, Y. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23263 · Cited by 28
“…pCREB Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by two major neuropathologic hallmarks: intracellular neurofibrillary tangles (NFT; Alonso et al., 1996) and extracellular senile plaques composed of amyloid beta (Ab; Cai et al., 1993; Suzuki et al., 1994).”
BackgroundDisease-associated patterns of acetylation stabilize tau fibril formation
Li, L., Nguyen, B. A., Mullapudi, V., Li, Y., Saelices, L., & Joachimiak, L. A. (2023) · Structure · doi:10.1016/j.str.2023.05.020 · Cited by 25
Pacheco, C. D., Elrick, M. J., & Lieberman, A. P. (2009) · Autophagy · doi:10.4161/auto.5.4.8364 · Cited by 20
Killick, R., Hughes, T. R., Morgan, B. P., & Lovestone, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.008 · Cited by 17
Centrosomes and cilia in neurodegeneration: Main actors or mere spectators?
Lattao, R. (2025) · Open Biology · doi:10.1098/rsob.240317 · Cited by 5
“These processes are particularly sensitive to changes in MT dynamics, and MTs destabilization has been linked to NDDs, including ALS [35,36], PD [37] and AD [38].”
Marien, J., Prévost, C., & Sacquin-Mora, S. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c06282 · Cited by 4
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“Tau, a microtubule-associated protein, subsequently becomes hyperphosphorylated and forms intracellular tangles [73,96].”
Metadata
- Authors
- Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K.
- Affiliations
- Universidad Nacional de Córdoba (AR)
- ORCID
- Iqbal, Khalid
- Venue
- Nature Medicine
- Published
- 1996-07
- Volume
- 2
- Issue
- 7
- Pages
- 783-787
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1969979382
- Cited by
- 859
- References
- 30
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 46 · 2023: 33 · 2022: 41 · 2021: 49 · 2020: 39 · 2019: 38 · 2018: 44 · 2017: 37 · 2016: 38 · 2015: 32 · 2014: 34 · 2013: 34 · 2012: 27
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag008076-09, 5r01ag005892-16, 5r03tw000507-06)
- National Institute on Aging (AG-05892, AG 08076)
- Fogarty International Center (TW 00507)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, tau protein, hyperphosphorylation, neurofibrillary tangles, paired helical filaments, tau aggregation, microtubule disassembly, dephosphorylation, alkaline phosphatase, tau antibodies, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Microscopy, Electron, Microtubules, Osmolar Concentration, Phosphorylation, Temperature, tau Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.